Literature DB >> 192804

Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.

D A Stringfellow, E R Kern, D K Kelsey, L A Glasgow.   

Abstract

Mice infected with encephalomyocarditis virus, Semliki Forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus developed a state of hyporeactivity to interferon induction. In general, the capacity of infected animals to produce interferon in response to inducers became progressively impaired during the course of infection. The severity and time of onset of hyporeactivity, however, were dependent upon the inducer and the nature of the viral infection. During viral infections associated with generalized hyporesponsiveness, a factor that could inhibit interferon production by murine cells in culture was identified in the serum. This serum hyporeactive factor may have mediated the development of hyporeactivity in vivo. Hyporeactivity of the host's interferon response was associated with progression of viral infection and may be partially responsible for the limited effectiveness of interferon inducers in the modification of viral infections, when administered after onset of symptoms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192804     DOI: 10.1093/infdis/135.4.540

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  The murine cytomegalovirus as a model for the study of viral pathogenesis and persistent infections.

Authors:  J B Hudson
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Variable effect of encephalomyocarditis virus on host defense mechanisms.

Authors:  H Faden; L A Glasgow; J C Overall
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

3.  Production of interferon and serum hyporeactivity factor in mice infected with murine cytomegalovirus.

Authors:  G C Tarr; J A Armstrong; M Ho
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

4.  Alteration of host defense mechanisms by murine cytomegalovirus infection.

Authors:  D K Kelsey; G A Olsen; J C Overall; L A Glasgow
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

5.  Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.

Authors:  D A Stringfellow
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

Review 6.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

Review 7.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

Review 8.  Rheumatoid arthritis--a virus disease?

Authors:  A M Denman
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1978

Review 9.  Chemotherapy of viral infections.

Authors:  D A Stringfellow
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

10.  Induction of alpha and beta interferons during the hyporeactive state of gamma interferon by Mycobacterium bovis BCG cell wall fraction in Mycobacterium bovis BCG-sensitized mice.

Authors:  A Nakane; T Minagawa
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.